Sphera Funds Management Ltd. Arbutus Biopharma Corp Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$0.87 - $2.89 $435,000 - $1.45 Million	-500,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.46 - $4.44 $730,000 - $2.22 Million	500,000 New	500,000 $0
Q4 2018 Feb 14, 2019	SELL	$3.5 - $9.66 $140,000 - $386,400	-40,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.85 - $12.35 $314,000 - $494,000	40,000 New	40,000 $378,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.